Healthcare
M&A Advisory
Technology
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
Aegerion Pharmaceuticals. United States. Announced Date 22/10/2010. Closed Date 27/10/2010. Deal value: $48m. Initial public offering. Industry: Aegerion Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies for rare diseases.